YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta] (2014)
- Authors:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.3109/10428194.2014.891028
- Subjects: LEUCEMIA (GENÉTICA); EXPRESSÃO GÊNICA; REGULAÇÃO GÊNICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Leukemia and Lymphoma
- ISSN: 1042-8194
- Volume/Número/Paginação/Ano: v. 55, n. 10, p. 2413–2415, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MACHADO NETO, João Agostinho et al. YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]. Leukemia and Lymphoma. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3109/10428194.2014.891028. Acesso em: 10 out. 2024. , 2014 -
APA
Machado Neto, J. A., Campos, P. de M., Saad, S. T. O., & Traina, F. (2014). YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]. Leukemia and Lymphoma. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3109/10428194.2014.891028 -
NLM
Machado Neto JA, Campos P de M, Saad STO, Traina F. YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta] [Internet]. Leukemia and Lymphoma. 2014 ; 55( 10): 2413–2415.[citado 2024 out. 10 ] Available from: https://doi.org/10.3109/10428194.2014.891028 -
Vancouver
Machado Neto JA, Campos P de M, Saad STO, Traina F. YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta] [Internet]. Leukemia and Lymphoma. 2014 ; 55( 10): 2413–2415.[citado 2024 out. 10 ] Available from: https://doi.org/10.3109/10428194.2014.891028 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
- IRS2 associates with JAK2 and may be involved in cell proliferation pathways in chronic myeloproliferative neoplasms
Informações sobre o DOI: 10.3109/10428194.2014.891028 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
